Literature DB >> 9697111

Prion proteins as memory molecules: an hypothesis.

P Tompa1, P Friedrich.   

Abstract

Prions are infectious agents widely implicated in a variety of mammalian neurodegenerative diseases generally referred to as transmissible spongiform encephalopathies. Their infectivity is primarily associated with an aberrant conformation of a host-encoded protein, the prion protein, induced by the prion itself in an autocatalytic reaction. The physiological function of this protein is not known. In this paper we suggest that alternative conformations of the prion protein, other than its pathological scrapie state, exist and that the self-sustaining autocatalytic propagation of these states underlies its normal cellular function. In kinetic model calculations we show that the prion protein may constitute a bi-stable molecular switch that can structurally encode and stably store information. A number of cases of prion involvement in normal cellular function and ample molecular detail of pathological prion propagation are cited and correlated to substantiate the implications of this tenet. Our contention is that the prion hypothesis should be extended to a wide variety of physiological processes. We propose that prion proteins are stable determinants of phenotype, operating in diverse functions possibly including memory.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697111     DOI: 10.1016/s0306-4522(98)00148-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  Case for an RNA-prion world: a hypothesis based on conformational diversity.

Authors:  Param Priya Singh; Anirban Banerji
Journal:  J Biol Phys       Date:  2011-02-08       Impact factor: 1.365

Review 3.  Long-term memory consolidation: The role of RNA-binding proteins with prion-like domains.

Authors:  Indulekha P Sudhakaran; Mani Ramaswami
Journal:  RNA Biol       Date:  2016-10-11       Impact factor: 4.652

4.  Energy landscapes of a mechanical prion and their implications for the molecular mechanism of long-term memory.

Authors:  Mingchen Chen; Weihua Zheng; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

Review 5.  Insoluble cellular prion protein and its association with prion and Alzheimer diseases.

Authors:  Wen-Quan Zou; Xiaochen Zhou; Jue Yuan; Xiangzhu Xiao
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

6.  Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain.

Authors:  Wen-Quan Zou; Xiangzhu Xiao; Jue Yuan; Gianfranco Puoti; Hisashi Fujioka; Xinglong Wang; Sandy Richardson; Xiaochen Zhou; Roger Zou; Shihao Li; Xiongwei Zhu; Patrick L McGeer; John McGeehan; Geoff Kneale; Diego E Rincon-Limas; Pedro Fernandez-Funez; Hyoung-gon Lee; Mark A Smith; Robert B Petersen; Jian-Ping Guo
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

7.  Modeling by assembly and molecular dynamics simulations of the low Cu2+ occupancy form of the mammalian prion protein octarepeat region: gaining insight into Cu2+-mediated beta-cleavage.

Authors:  M Jake Pushie; Hans J Vogel
Journal:  Biophys J       Date:  2008-09-12       Impact factor: 4.033

Review 8.  The Role of Functional Prion-Like Proteins in the Persistence of Memory.

Authors:  Kausik Si; Eric R Kandel
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-04-01       Impact factor: 10.005

9.  Amyloidogenic Oligomerization Transforms Drosophila Orb2 from a Translation Repressor to an Activator.

Authors:  Mohammed Repon Khan; Liying Li; Consuelo Pérez-Sánchez; Anita Saraf; Laurence Florens; Brian D Slaughter; Jay R Unruh; Kausik Si
Journal:  Cell       Date:  2015-12-03       Impact factor: 41.582

10.  Phenoxodiol treatment alters the subsequent response of ENOX2 (tNOX) and growth of hela cells to paclitaxel and cisplatin.

Authors:  D James Morré; Nicole McClain; L-Y Wu; Graham Kelly; Dorothy M Morré
Journal:  Mol Biotechnol       Date:  2009-01-21       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.